It seems logical for the two largest pharma suppliers in the world, one of active ingredients and another of generic drugs, to trade more, but forward movement between the Indian and Chinese industries may not be straightforward.
Indian firms are hoping to finally enter China’s generics market after years of testing the waters, while China is hoping...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?